Accendra Health stock gets a 283,554-share CEO grant

According to StockTitan on October 6, 2026, Accendra Health (ISIN US6907321029) disclosed a 283,554-share restricted stock grant for CEO Kenneth Gardner-Smith dated October 5, 2026. Accendra Health stock closed at USD 0.46 on the NYSE on October 7, 2026, down 2.02 percent.

CEO grant adds a concrete signal

The Form 4 shows Gardner-Smith's direct holdings at 369,667 shares after the grant. The award vests one-third per year over three years, making the leadership transition a measurable compensation event rather than a general management change.

The grant came after Gardner-Smith took over as president and CEO on October 5, 2026. For investors, the key question is whether the new leadership can reverse the operating pressure reflected in the latest quarterly figures.

Q2 revenue reached USD 613.23 million

MarketBeat reported that Accendra Health generated USD 613.23 million in Q2 2026 revenue and adjusted EPS of negative USD 0.19, compared with a consensus estimate of negative USD 0.13. The revenue figure was paired with a 11.41 percent negative net margin in the same quarterly context.

In its Q2 2026 earnings call, Fortune reported adjusted EBITDA above USD 60 million and full-year 2026 guidance of USD 2.45 billion-USD 2.55 billion in revenue and USD 300 million-USD 320 million in adjusted EBITDA. Payer collection issues reduced revenue and adjusted EBITDA by USD 20 million in the first half of 2026, according to the call.

Consensus target stands above the stock

On October 7, 2026, Stockanalysis listed a Hold consensus from five analysts and an average price target of USD 1.51. The target lies 228.3 percent above the October 7 closing price of USD 0.46, a comparison that highlights how widely the market value has diverged from analyst expectations.

The same operating picture contains a balance-sheet counterweight. Accendra Health's Q2 2026 call put total debt at USD 1.72 billion after a reduction of almost USD 400 million since March, while full-year free cash flow was guided to break even to slightly positive.

Accendra Health stock stays near its yearly low

Accendra Health stock traded within a 52-week range of USD 0.44 to USD 5.60 as of October 7, 2026. Its USD 36.2 million market capitalization and 833,225-share session volume underline the small-cap scale of the transition story.

More news and analyses on Accendra Health stock